CLM
ALXN

ClearBridge LLC (Maryland)’s Alexion Pharmaceuticals ALXN Stock Holding History

ClearBridge LLC (Maryland)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$11.6M Buy
119,295
+9,545
+9% +$1.13M 3.53% 5
2018
Q3 		$15.3M Sell
109,750
-709,383
-87% -$89M 3.74% 5
2018
Q2 		$798K Sell
819,133
-28,365
-3% -$3.32M 0.01% 140
2018
Q1 		$94.5M Buy
847,498
+217,043
+34% +$25.9M 2.1% 6
2017
Q4 		$75.4M Sell
630,455
-227
-0% -$27.6K 1.57% 19
2017
Q3 		$88.5M Sell
630,682
-196,158
-24% -$26.7M 1.91% 11
2017
Q2 		$101M Buy
826,840
+149,780
+22% +$17.4M 2.13% 10
2017
Q1 		$82.1M Sell
677,060
-12,817
-2% -$1.65M 1.77% 17
2016
Q4 		$84.4M Buy
689,877
+308
+0% +$37.7K 1.91% 17
2016
Q3 		$84.5M Buy
689,569
+98,670
+17% +$12.7M 1.61% 29
2016
Q2 		$69M Buy
590,899
+216,185
+58% +$30.7M 1.37% 37
2016
Q1 		$52.2M Sell
374,714
-390
-0.1% -$57.3K 1.03% 42
2015
Q4 		$71.6M Sell
375,104
-11,170
-3% -$1.95M 1.37% 34
2015
Q3 		$60.4M Sell
386,274
-90,820
-19% -$16.6M 1.23% 37
2015
Q2 		$86.2M Buy
+477,094
New +$82.3M 1.54% 32

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge LLC (Maryland)'s ALXN Position: Q4 2018 in Review

ClearBridge LLC (Maryland) increased its Alexion Pharmaceuticals (ALXN) stake by 8.7% in Q4 2018, buying an estimated $1.13M and bringing the position to 119,295 shares worth $11.6M. The position accounts for 3.53% of the portfolio, ranked #5.

ClearBridge LLC (Maryland) first reported a position in ALXN in Q2 2015 and has held it in 15 quarters since. The position peaked at $101M in Q2 2017. 609 funds tracked by Wall St. Rank hold ALXN as of Q4 2018.

  • ClearBridge LLC (Maryland) held 119,295 shares of Alexion Pharmaceuticals worth $11.6M as of Q4 2018.
  • ClearBridge LLC (Maryland) bought 9,545 Alexion Pharmaceuticals shares in Q4 2018, an estimated $1.13M.
  • Alexion Pharmaceuticals made up 3.53% of ClearBridge LLC (Maryland)'s portfolio in Q4 2018, its #5 holding.
  • ClearBridge LLC (Maryland) first reported a position in Alexion Pharmaceuticals in Q2 2015 and has held it in 15 quarters since.
  • ClearBridge LLC (Maryland)'s Alexion Pharmaceuticals position peaked at $101M in Q2 2017.
  • 609 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2018.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q4 2018, filed 14 Feb 2019.